Renal failure Flashcards

1
Q

Main functions of the kidney?

A
  • Fluid balance
  • electrolyte balance
  • RBC production
  • vitamin D production
  • Blood pressure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define acute kidney injury (AKI)

A
  • abrupt deterioration in renal function, usually over hours or days
  • usually (but not always) reversible over days or weeks
  • AKI usually recognised by a falling urine output, rising urea and creatinine or both.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

General causes of AKI?

General outcome?

A

AKI may result from:

Prerenal causes (85%) –> reduced kidney perfusion leads to a falling GFR

Renal causes(5%) –> injury to glomerulus, tubule or vessels (intrinsic renal disease, or exposure to nephrotoxins)

post renal causes (10%) –> Urinary tract obstruction, functioning kidneys cannot excrete urine with back pressure

Outcome: impaired clearance and regulation of metabolic homeostasis, altered acid/base and electrolyte regulation, impaired volume regulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pathophysiology of AKI?

A
  • Prerenal –>
    • impaired renal perfusion, renal response is to enhance sodium and water reabsorption.
    • Baroreceptors in carotid artery/ aortic arch respond to lower BP with ↑ SNS outflow.
    • vasoconstriction of the efferent arteriole and dilation of afferent arteriole maintains glomerular filtration in narrow range
    • decreasing perfusion promotes activation of RAAS system –> ATii vasoconstricts, promotes aldosterone release, ↑in Na/H2O absorption, higher osmolarity of the blood stimulates ADH release from hypothalamus, increase water reabsorption in collecting duct.
  • Renal –>
    • acute tubular necorsis due to prolonged/severe ischaemia, most common AKI
    • preceded by impaired perfusion and tissue hypoxaemia –> microvascular injury and tubular ischaemia
    • hypoxemia –> acute ROS, cellular dysfunction and death
    • immune activation –> complement, neutrophil activation w membrane attack complexes
    • can also be caused by drugs/ endotoxins/ radiocontrast media
  • Post renal –>
    • obstruction leads to increased intratubular pressure
    • leads to tubular ischaemia and atrophy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Causes of AKI?

A

Pre renal:

  • low vascular volume –> haemorrhage, D&V, burns, pancreatitis
  • decreased cardiac output –> cardiogenic shock/ MI
  • systemic vasodilation –> sepsis, drugs
  • Renal vasoconstriction –> NSAID/ACEi/ARB/hepatorenal syndrome

Renal:

  • Glomerular –> glomerulonephritis, ATN (avascular tubular necrosis)
  • interstitial –> drug reaction, infection, infiltration (sarcoid)
  • vessels –> vasculitis, haemolytic -uremic syndrome, thrombotic thrombycytopenic purpura, disseminated intravascular coagulation

Post renal:

  • within tract –> stone, renal tract malignancy, stricture, clot
  • extrinsic compression –> pelvic malignancy, prostatic hypertrophy, retroperitoneal fibrosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How do we classify AKI?

A

KDIGO definition:

  • Increase in serum creatinine by ≥0.3 mg/dL within 48 hours
  • increase in serum creatinine to ≥ 1.5 times baseline - known or presumed to have occured within prior 7 days
  • Urine volume <0.5 mL/kg/hour for 6 hours.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Define chronic kidney disease

A
  • Chronic kidney disease = abnormalities in kidney structure or function, present for ≥3 months
  • With implications for health
  • Means a GFR less than 60mL/min/1.73m2
  • often presence of one or more markers of kidney damage:
    • albuminuria/proteinuria
    • urine sediment abnormalities (haematuria)
    • electrolyte abnormalities
    • histological/structural abnormalities detected by histology/imaging
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Common causes of chronic kidney disease?

A
  • Most common cause = Diabetes (diabetic nephropathy)
  • Hypertension second most common cause, hypertension is both a cause and consequence of CKD (hypertensive renal disease).
  • Less common:
    • polycystic kidney disease
    • obstructive uropathy
    • glomerular nephrotic and nephritic syndromes:
      • focal segmental glomerulosclerosis
      • membranous nephropathy
      • lupus nephritis
      • amyloidosis
      • rapidly progressive glomerulonephritis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the general pathophysiology of CKD?

A
  • regardless of method of renal injury (diabetes/HTN/glomerular disorders):
    • in response to renal injury there is an increase in intraglomerular pressure with glomerular hypertrophy (kidney attempts to adapt to nephron loss to maintain GFR)
    • mesangial cell expansion/inflammation and glomerular scarring
    • angiotensin II production - contributes to scarring
    • progressive renal scarring and loss of function
    • tubular disease due to reduction in blood supply and infiltration of inflammatory cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Key features in history of CKD?

A
  • Signs and symptoms often vague:
    • Fatigue (may be related to uraemia or anaemia (decreased EPO) )
    • nausea & V (related to urea rise, more advanced kidney disease)
    • ankle swelling/oedema (GFR decrease, Na+ & H2O retained
  • Symptoms of uraemia = raised level of blood urea and nitrogenous waste products normally eliminated by the kidneys
    • N & V
    • Pruritus
    • restless legs
    • very advanced uraemia –> seizure/coma
  • Can present with lack of urine output
    • fluid overload –> dysponea and orthopnea (Pulmonary oedema)
  • Urine appearance –> “foamy” = proteinuria, “tea/cola coloured” = haematuria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Examination features for CKD?

A
  • Hypertension and peripheral oedema (due to sodium retention, ECF volume expansion, RAAS activation)
  • pallor –> anaemia
  • Signs of end organ damage:
    • Fundoscopic eye exam:
      • Diabetes –> microaneurysms, dot haemorrhages, cotton wool spots, proliferative diabetic retinopathy (advanced) –> neovascularisation, macular oedema, hard exudates, retinal detachments
      • Hypertensive retinopathy –> arteriolar narrowing, AV nipping (compression of venules at sites of Arteriovenous crossing), retinal haemorrhages, hard exudates, cotton wool spots, optic disc swelling
  • PR exam –> prostate enlargement
  • Rashes and arthritis on MSK –> autoimmune cause
  • Glomerular nephrotic/nephritic syndrome –> more acute presentation, v hypertensive, periorbital and peripheral oedema
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Classification of CKD?

A

Classification of CKD is based on GFR and/or albuminuria

GFR classification (ml/min/1.73m2) - kidney damage with:

G1: >90 normal/increased GFR

G2: 60-89 mildy decreased GFR

G3a: 45-59 moderately decreased GFR

G3b: 30-44 moderately decreased GFR

G4: 15-29 severely decreased GFR

G5: < 15 end stage kidney disease

OR Albuminuria (mg/24 hours) classification:

A1: < 30 optimal/high normal = ACR of 3

A2: 30-300 High = ACR of 3-30

A3: >300 very high/nephrotic = ACR of > 30

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How can we assess risk of adverse outcomes in CKD?

A

KDIGO guidelines where GFR and albuminuria can be assessed together to determine risk of adverse outcomes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Revise stages and symptoms of CKD

What is needed to classify patients in stages 1 & 2 of CKD?

A

To classify patients in stages 1&2 of CKD (early disease):

1) persistent microalbuminuria
2) persistent proteinuria
3) persistent haematuria
4) structural abnormality
5) biposy proven chronic glomerulonephritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Key features in history for AKI?

A

AKI often asymptomatic - general sx include nausea and vomiting

Prerenal:

  • hypovoleamia sx –> thirst/dizziness/tachycardia/ oliguria (urine output less than 500ml in 24 hrs) or anuria
  • Advanced cardiac failure –> paroxysmal nocturnal dysponea and orthopnea
  • Hx of excessive fluid loss e.g. haemorrhage/D&V

Renal:

  • Patients present with acute tubular necrosis - due to infection, nephrotoxic drug exposure or major surgery
  • nephritic syndrome - rash, haematuria, oedema with HTN
  • Drug hx - acyclovir, methotrexate, triamterene, NSAIDS, antibiotics (sulfonamides or betalactam)
  • Rhabdomyolysis –> myoglobin release from damaged muscles - suspect in patients w muscle tenderness, excessive exercise, limb ischaemia, drug or alcohol abuse.

Post renal:

  • Prostatic –> urgency/ frequency/ hesitancy
  • previous surgery or malignancy, kidney stones (Nephrolithiasis) –> flank pain (Dermatomes T10-S4) , haematuria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

LO: Identify common and important causes of acute kidney injury:

Already known causes:

Key cause or RENAL AKI = glomerulopnephritis / glomerulonephritides

What is glomerulonephritis?

What is it broken down into and what is the main process in these two groups?

Cardinal features of each?

A
  • Are a group of diseases, characterised by damage to the glomerular apparatus, dividided into Nephrotic and nephritic glomerulonephritides depending on where the condition lies on a clinical spectrum. Note often called glomerulonephritis but not always inflammatory process!
  • 1) Proteinuric diseases –> Damage to glomerular podocytes / non inflammatory alteration in glomerular structure to podocytes –> causes proteinuria –> causes NEPHROTIC syndrome
    • Nephrotic syndrome cardinal features:
      • Hypoalbuminaemia
      • >3.5g proteinuria/day
      • dyslipidaemia and lipiduria
      • Oedema
  • 2) Inflammatory disease –> inflammation and cell proliferation, damage to glomerular cells and the basement membrane, breaks in GBM leads to haematuria and proteinuria –> NEPHRITIC syndromes:
    • acute glomerulonephritis –> cardinal features:
      • abrupt onset haematuria –> red blood cell casts
      • non nephrotic range proteinuria
      • oedema
      • HTN
      • transient renal impairment
    • Rapidly progressive glomerulonephritis –> features of acute plus focal necrosis/ crescents, progressive renal failure over weeks.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

AKI management?

A
  • Prerenal –> decreased perfusion therefore fluids/blood/ vaspressors
  • Renal –> refer for biopsy and specialist treatment
  • Post renal –> catheter, nephrostomy, urological intervention
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Pathophysiology of nephrotic glomerulonephritis?

A
  • Key triad of 1) hypoalbuminaemia, 2) proteinuria 3) oedema
  • Damage to podocytes leads to physically larger filtration pores in the glomerular filtration barrier which allows the passage of larger molecules:
    • Abnormal function in minimal change disease (25% all cases)
    • immune mediated in membranous nephropathy
    • injury/death in focal segmental glomerulosclerosis
  • damage leads to loss of proteins leading to proteinuria and hypoalbuminaemia
  • protein loss leads to decrease in oncotic pressure in vascular compartment –> tissue oedema
  • hypoalbuminaemia - increased catabolism of reabsorbed protein (largely albumin) in proximal tubules
  • hyperlipidaemia occurs via unknown mechanism, thought to be liver induced increase in synthesis of lipoproteins (apolipoB/C) as direct response to low albumin. LDL increase due to internalisation of LDL receptors in liver, no change in HDL. Reduced clearance of triglycerides too.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the main nephrotic syndromes?

A
  • Minimal change disease
  • focal segmental glomerulosclerosis
  • membranous nephropathy
  • membranoproliferative GN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Minimal change disease:

Define

Pathophysiology

Who is commonly affected?

A

Definition: Minimal change nephropathy :

  • Light MS –> appearance normal glomeruli
  • EM –> fusion of foot processes but no immune compleses or anti GBM antibody on immunofluroescence

Pathophysiology:

Immature CD34 T cell mediated, and interleukins –> causes effacement/flattening of podocytes.

Drugs been implicated –> NSAID/lithium/antibiotics

Atopy and allergies –> present in 30% cases

infections –> hep C/HIV/TB rarer

Who is affected? --> more common in children (particularly boys 2:1 M:F ratio) 2-8 years old, uncommon below 1 yrs, M:F equal in adults.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Key signs on history and exam for minimal change disease?

A
  • Generalised and/or facial oedema
  • age between 1-8 yrs
  • hx of recent viral illness
  • absence of haematuria
  • Hx of lymphoma or leukaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Investigations for minimal change disease?

A
  • Urinalysis –> proteinuria, hyaline casts
  • urine protein/creatinine ratio
  • serum albumin –> low
  • serum lipid –> high triglyceride and cholesterol
  • serum creatinine and urea –> normal or slightly elevated urea, decreased sodium level
  • GFR –> should be normal
  • LFT –> rule out hepatitis
  • renal ultrasound –> confirm kidney size and structure, in nephrotic syndrome kidneys should appear normal
  • renal biopsy –> normal light microscopy but podocyte effacement on electron microscopy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Management for minimal change disease?

A
  • Corticosteroids therapy (85% response)
    • prolonged prednisilone
    • Note may be at increased risk of infection and side effects –> growth failure/obesity
    • can use cytotoxic agents to induce remission (ciclosporin or cyclophosphamide)
    • if frequent relapse occurs with corticosteroid use consider renal biopsy to confirm diagnosis
  • For oedema:
    • low Na+ diet and fluid restriction
    • If severe:
      • albumin IV
      • furosemide IV
  • does not progress to CKD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

LO: Identify common and important causes of acute kidney injury:

Already known causes:

Key cause or RENAL AKI = glomerulopnephritis / glomerulonephritides

Nephrotic syndrome - What is focal segmental glomerulosclerosis?

How many cases of nephrotic syndrome are caused by FSGS?

What types are there?

What is the pathophysiology of each type?

A
  • Focal segmenetal glomerulosclerosis: Evidence of focal (some, not all nephrons) segemental (part of, not all of glomerulus) sclerosis (scarring) which can present with nephrotic syndrome:
    • ​Accounts for 40% of cases
      • Chronic pathological process caused by injury to podocytes
      • manifests with proteinuria, progresses to nephrotic syndrome and ESRF.
  • Primary FSGS –> circulating permeability factor that causes increased protein leak
  • Secondary FSGS –> seen as secondary phenomenon as response to reduced number of functioning nephrons:
    • reduced nephron number (HTN, obesity, sickle cell, IgA nephropathy)
    • mutation in podocyte genes
    • viruses –> HIV/ cytomegalovirus, epstein - barr
    • drugs –> heroin, anabolic steroids, lithium, ciclosporin
25
Q

Focal segmental nephrosclerosis: Key features in hx?

A
  • Oedema –> facial and peripheral
  • Foamy urine –> high levels protein in urine
  • hypertension –> increased salt retention and volume overload
  • Risk factors:
    • male
    • black race
    • family hx of FSGS
    • Drug hx –> heroin, lithium
    • PMHx:
      • chronic viral infection –> HIV
      • solitary kidney
      • obesity
26
Q

Investigations focal segmental glomerulosclerosis?

A
  • Serum urea and creatinine –> elevated
  • GFR – >decreased
  • Urinanalysis w microscopy –> proteinuria, fatty casts, absent red cell casts
  • urine protein: creatinine ratio
  • 24 hr urine collection for protein –> patients asymptomatic may have minimal, symptomatic 3g/24hrs
  • serum albumin –> hypoalbuminaemia
  • serum lipids –> increased Total cholesterol and LDL
    *
27
Q

Management of primary focal segmental sclerosis?

Management of secondary focal segemental sclerosis?

A

primary –> corticosteroid, ACEi, low fat/Na+ diet, diuretic, statin

Secondary –> treat underlying causes, ACEi, statin, furosemide

Note: FSGS will progress to CKD/renal failure as local lesions progress to global sclerosis. ACS & CVA due to hyperlipidaemia and HTN.

28
Q

Causes of AKI: Nephrotic syndromes:

What is Membranous nephropathy?

How many cases of nephrotic syndrome does it account for?

A
  • Membranous nephropathy –> accounts for 25% all cases of nephrotic syndrome
  • immune complex mediated glomerular basement membrane damage, thickening AND podocyte damage leading to thickened basement membrane in a spike and dome pattern, podocyte effacement
29
Q

Complications of AKI?

A
  • CKD which can lead to ESRD
  • Metabolic acidosis (non volatile acid accumulation)
  • hyperkalaemia (impaired excretion and tissue breakdown)
  • oedema (pulmonary and peripheral)
  • uraemia (lethargy and confusion
  • hyperphosphatemia
30
Q

Membranous nephropathy: pathophysiology?

A
  • Primary membranous glomerulopathy = idiopathic (majority patients)
  • Secondary membranous glomerulonephropathy —>
    • drugs (penicillinamine, gold, NSAIDS)
    • infection (hep B/C, plasmodium malariae)
    • cancer (lung/colon/stomach/breast and lymphoma)
    • kidney transplantation and sickle cell
  • Pathophysiology –>
    • immune complexes (antibodies whether autoimmune or infection) are deposited in sub epithelial space in glomerulus. (Between basement membrane and podocytes).
    • Leads to complement activation (C5b-C9), membrane attack complex activation on podocytes and mesangial cells.
    • Leads to podocyte effacement and mesangial cell death.
    • Mesangial cells normally remove immune complexes, therefore build up.
    • Complement leads to immune cell recruitement and activation, leads to basement membrane damage.
    • Basement mebrane deposited inbetween areas of immune complexes, leads to characteristic “Spiked” thickening of BM.
31
Q

Membranous glomerulonephropathy: History and exam?

A

History:

  • ​HTN
  • oedema - periorbital and lower legs
  • foamy urine
  • fatigue/malaise
  • PMH: autoimmune disease, hepatitis B/C, syphilis, malignancy
  • Drug Hx: NSAIDs, penicillamines, lithium, gold

Examination:

  • Elevated BP
  • Xanthelasma
  • white banding of nails (Muehrcke’s lines) - hypoalbuminaemia
  • oedema or facial oedema
32
Q

Membranous glomerulonephropathy:

Investigations

A
  • Bloods:
    • Serum creatinine and creatinine clearance
    • GFR (Calculated of serum creatinine)
    • serum urea
    • serum albumin –> hypoalbuminaemia seen in nephrotic syndrome
    • lipid profile –> hyperlipidaemia
  • Urine microscopy –> oval fat bodies and fatty casts
  • Urine protein: creatinine ratio : may be followed by 24 hour urine collection - may reveal proteinuria (>3.5g/24hrs) –> nephrotic syndrome

Imaging: renal USS (rule out renal artery stenosis/ other causes), renal biopsy followed by lightMS and electron MS for diagnosis (specialist referral)

33
Q

Membranous nephropathy: management

A
  • low salt diet, low protein diet - limit oedema
  • ACEi - protect renal function and tx HTN
  • statin - lipid lowering
  • furosemide - oedema
  • corticosteroids - inhibit immune pathway
  • treat underlying causes

Can progress to CKD, MI, stroke, PE, DVT, infection

34
Q

Nephrotic syndrome: Membranoproliferative glomerulonephritis (10%)

What is it?

How many cases of nephrotic syndrome does it account for?

A
  • accounts for 10% of nephrotic syndromes - uncommon cause primarily in children and yound adults
  • Membranoproliferative glomerulonephritis –> immune complex or abnormal complement pathway mediated glomeruluar endothelial damage, (subendothelial) basement membrane thickening and mesangial cell proliferation ultimately causing nephrotic syndrome
  • C3 deficiency
35
Q

Membranoproliferative glomerulonephritis:

Hx

Exam

A
  • elevated bP
  • oedema
  • Foamy urine
  • infection - c3 complement deficiency
36
Q

What is nephritic glomerulonephritis?

What are the cardinal features?

A

Nephritic glomerulonpehritis = glomerular damage due to inflammation

Clinically defined by:

1) haematuria
2) proteinuria (under nephrotic levels of 3.5g/24hrs)
3) HTN + oedema (Salt and water retention)
4) oliguria
5) uraemia

37
Q

what are the nephritic syndromes?

A
  • Nephritis can present asymptomatically as incedental finding, is distinguished from rapidly progressive by lack of cellular necrosis and rate of renal decline.
    • syndromes should be seen as a continuum
  • Immunoglobulin A nephropathy
  • postinfectious glomerulonephritis
  • rapidly progressive glomerulonephritis
    • vasculitis
    • anti-glomerular basement membrane GN (Goodpasture disease)
38
Q

What is the pathophysiology underlying glomerulonephritis?

A
  • immune mediated injury to the glomeruli with both cellular and humoral components
  • Cellular = T lymphocytes, macrophages/dendritic cells
  • humoral = antibodies, immune complexes, complement
  • inflammatory mediators = cytokines, chemokines, coagulation cascade
  • injury normally occurs as a consequence of the release of inflammatory mediators which lead to structural and functional disease in glomeruli
  • inflammation and damage to glomerulus leads to increased permeability to RBC’s and proteins –> damage to filtration barrier leads to decreased GFR, presentation of oliguria. As a result, hypertension and oedema is present.
39
Q

Nephritic syndromes:

What is Rapidly progressive glomerulonephritis?

A

Rapidly progressive glomerulonephritis = any aggressive glomerulonephritis which progresses to renal failure over days/weeks

Glomerular haematuria (red blood cell casts or dysmorphic red blood cells), with rapidly evolving acute kidney failure over weeks- months and focal glomerular necrosis

with or without crescent development on renal biopsy

crescent = aggregate of macrophages and epithelial cells in bowman’s space - can undergo sclerosis leading to rapid decrease in GFR and renal failure

40
Q

Nephritic syndromes:

investigations for rapidly progressive glomerulonephritis?

management?

complications?

A
  • Ix: renal biopsy –> crescent shape on light microscopy, all differ on immunofluroescence
  • Management: corticosteroids, treat underlying cause
  • complications: rapidly progresses to renal failure w/out tx
41
Q

What are the types of rapidly progressive glomerulonephritis?

A
  • 1) Anti GBM antibody - 3%
    • goodpasture syndrome
  • 2) immune complex disease - 45%
    • postinfectious (staphylococci/streptococci)
    • henoch schonlein purpura (immunoglobulinA and systemic vasculitis)
    • lupus
    • immunoglobulin A nephropathy
  • 3) pauci immune disease - 50% cases (lacks immune deposits)
42
Q

Nephritic glomerulonephritis:

What is IgA nephropathy?

Pathophysiology?

A

IgA nephropathy = Defined by presence of IgA immune deposits in the mesangial cells, often accomapanied by C3 and IgG.

Thought in susceptible individuals IgA1 becomes abnormally glycosylated in hinge region, leads to autoantibody production - anti-glycan igG- immune complexes form and deposit in the mesangium

leads to activation of complement pw, recruitment of immune cells, glomerular injury and scarring.

Damage to filtration barrier –> enables RBC’s and protein to cross

43
Q

Nephritic syndromes:

IgA nephropathy:

features on hx and exam?

A
  • haematuria - 50% macro
  • proteinuria (rarely nephrotic range)
  • HTN and oedema (rarer)
  • 1/3 asymptomatic w microscopic haematuria
  • More common in:
    • M: F 2:1
    • 20-30 yrs
    • asian/white
    • IgA vasculitis –> also known as henoch schonlein purpura –> have extra renal sx e.g. rash/abdo pain/ arthralgia
    • chronic liver disease –> liver does not clear IgA
    • HIV
44
Q

IgA nephropathy:

investigations?

A

Investigations:

  • Urinalysis (haematuria and proteinuria)
  • urine Ms&C –> exclude UTI
  • GFR
  • Imaging: Renal USS, CT KUB
  • Special tests: renal biopsy (mesangial IgA deposition)
45
Q

IgA nephropathy: Management?

A
  • Low risk progression –> monitor
  • Hypertension or rise in proteinuria develops –> ACEi/ARB
  • Progressive –> ACEi/ARB, fish oil, corticosteroids
46
Q

Nephritic syndromes:

Henoch-schonlein purpura (IgA vasculitis)

A

Henoch-Schonlein purpura (IgA vasculitis) = small vessel vasculitis due to immune complex deposition, inflammation of the vessel itself and bleeding –> leads to rash, abdominal pain/bleeding, arthritis/arthralgia, glomerulonephritis

Pathophysiology –> multiple triggersm (strep throat infection) lead to IgG - antigen immune complex formation, in kidney same process as IgA nephropathy. Complex deposition in joints –> arthritis, in skin vessels = purpura, in GI tract vessels –> pain / bleeding

47
Q

Nephritic syndromes: Henoch schonlein purpura / IgA vasculitis

Who is commonly affected?

Key features on Hx?

Key features on exam?

A
  • most common vasculitis in childhood –> male gender, 3-15 years, history of prior URTI
  • Arthralgia (painful joints) –> knee and ankles, can be oedematous
  • abdominal pain, N &V
  • Rash —> palpable purpura, non blanching
  • renal disease –> haematuria, proteinuria, RBC casts
  • (can also get scrotal pain or swelling (10%))
48
Q

Henoch schonlein purpura/ IgA vasculitis:

investigations?

Management?

A
  • Urinalysis –> RBC/protein
  • Urea and creatinine (may be high)
  • serum IgA (may be high)
  • USS abdomen or testicles –> to show intessusception (bowel segment prolapses into another) or perforation
  • renal biopsy (IgA in mesangium)
49
Q

management henoch schonlein purpura/IgA vasculitis?

A
  • most cases resolve spontaneously in weeks - symptomatic tx
  • joint pain/ abdo pain –> ibuprofen / paracetamol
  • severe abdo pain (N &V) /scrotal pain –> prednisilone
  • If renal impairment –> nephrotic level proteinuria, decline renal function –> IV corticosteroids
50
Q

Nephritic syndromes: Post streptococcal glomerulonephritis

A
  • Definition: deposition of antibody-streptococcal antigen immune complexes in glomerular basement membrane and subepithelial space leading to inflammation, glomerular damage and resulting nephritic syndrome
  • 2 weeks post strep throat or 3-6 weeks post strep skin infection, host antibody strep antigen immune complexes deposit in GBM/ subepithelial space –> inflammation and damage to BM and podocytes, leads to haematuria and proteinuria
  • Glomerular damage leads to decreased GFR –> fluid retention and Na+ retention –> HTN and oedema
51
Q

Hx / exam post strep glomerulonephritis?

A
  • Commoner in children
  • haematuria
  • recent strep infection - throat, otitis media or cellulitus
    • group A Beta haemolytic streptococcus
  • oedema
  • HTN
52
Q

investigations for post strep glomerulonephritis?

management?

A
  • urinalysis -> blood and protein
  • GFR
  • serology : low complement (C3) and serum anti-DNAse (strep specific antibody)
  • imaging -> renal USS
  • special –> renal biopsy (if deterioration)

Management: BP control w diuretics, salt restriction for oedema, dialysis if necessary. Corticosteroids.

53
Q

Nephritic:

What is

Antiglomerular basement membrane disease / Goodpasture disease?

Pathophysiology?

A

Definition: Goodpastures disease (also known as pulmonary- renal syndrome), consists of glomerulonephritis and pulmonary haemorrhage. Caused by autoantibody to alpha 3 chain of type 4 collagen found in basement membrane of alveoli and glomeruli.

Autoantibodies vs type IV collagen present in glomerular and alveolar basement membrane. Autoantibody binding leads to activation of classical complement pathway –> inflammatory response, damages BM, endothelium and parenchyma.

Leads to cough, haemoptysis in lungs, restrictive lung disease due to scarring.

In kidneys, damage to filtration barrier –> nephritic syndrome

54
Q

Nephritic disease: Antiglomerular basement membrane disease / Goodpasture disease

Who is affected?

Hx?

A
  • Uncommon, 2% glomerulonephritides, male more common, white more common
  • Hx:
    • Lungs: Cough, haemoptysis, SOB, crackles on exam
    • Kidneys: haematuria, oedema, oliguria (reduced urine output)
    • fever and nausea
55
Q

Nephritic syndromes: Goodpastures disease/ anti GBM disease

investigations?

A
  • Urinalysis–> protein and blood
  • Urea and creatinine (elevated)
  • GFR (decreased)
  • Renal biopsy –> IgG staining immunofluorescence
  • antiGBM titre –> positive
56
Q

Nephritic syndromes: Goodpastures disease/ anti GBM disease

management

A

Oral corticosteroid plus prophylaxis against osteoporosis, gastritis, pneumonia

Plasmapheresis –> for 10-14 days until antiGBM undetectable

Cyclophosphamide

57
Q

Investigations for general kidney disease?

A
  • Blood: FBC–> normocytic anaemia
  • U&E’s –> creatinine, urea, electrolytes (K high, Na low, bicarb low)
  • Glucose –> DM
  • eGFR
  • Serum albumin : Nephrotic syndrome
  • Bone profile –> calcium, phosphate, ALP magnesium
  • cholesterol and triglycerides –> dyslipidaemia in nephrotic
  • serology –> autoantibody screen
  • Urine: Dipstick, protein: creatine, culture
  • Imaging: xray (stones) USS, CT or MRI if abnormal USS
  • Biopsy
58
Q

CKD management?

Complications of CKD?

A
  • monitor eGFR, control BP, control underlying condition, supplement
  • G1/2/3/4 without uraemia –> ACEi/ARBs target < 140/90, statins
  • G5 or uraemic –> dialysis or transplant
  • hormonal –> EPO, iron, ergocalciferol

Complications: hormonal –> decreased vitamin D, leads to renal osteodysophy, decreased EPO leads to normocytic normochromic anaemia, increased renin leads to HTN which can futher impair renal function

ESRD , AKI

more likely to die of CVD than to need renal replacement – > leading causes of CKD are DM and HTN (leading causes of CVD).

59
Q

How does haemodialysis work?

A

Hemodialysis works by diffusion and ultrafiltration through a semi-permeable membrane. Excess solute moves from blood to dialysate by diffusion and excess fluid moves from blood to dialysate under hydrostatic pressure.